
Please try another search
Porton Pharma Solutions Ltd. provides contract development and manufacturing organization (CDMO) solutions for small molecules, tides, biologics, and conjugates from pre-clinical to commercial. It has a strategic collaboration with Aojin Life Sciences to advance XDC conjugate drugs; and strategic partnership with Porton Pharma Solutions and Dragon Sail Pharmaceutical to build a new ecosystem for ADC drug development, production, and supply chain. The company operates in China and internationally. The company was formerly known as Porton Fine Chemicals Ltd. and changed its name to Porton Pharma Solutions Ltd. in January 2018. Porton Pharma Solutions Ltd. was incorporated in 2005 and is headquartered in Chongqing, China.
Name | Age | Since | Title |
---|---|---|---|
Nianfeng Ju | 53 | - | Chairman & GM |
Ying Xue | 57 | 2020 | Non-Independent Director |
Jinwei Pang | 57 | 2022 | Independent Director |
Lina Hu | 66 | 2022 | Non-Independent Director |
Lin Yuan | 61 | 2022 | Independent Director |
Guohua Cao | 58 | 2020 | Independent Director |
Weiqiang Yang | 58 | 2021 | Non Independent Director |
Guojun Cao | 60 | 2022 | Non-Independent Director |
Yongqing Tan | 70 | 2019 | Non-Employee Chairman of the Supervisory Board |
Yuchen Wu | 33 | 2022 | Non-Employee Supervisor |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review